TPX2 is known to regulate AURKA and interacts with RHAMM [71], which is known to correlate with centrosome amplification and with poor prognosis in MM [72]; the AURKA inhibitor is a potential treatment for MM [73]. The gene discussed is HMMR; the disease is Miyoshi myopathy.